Aaron Weitzman

It’s a moment of opportunity for healthcare deals, said TPG’s Jeff Rhodes; LLR urges shippers to embrace tech

TPG's Rhodes discusses healthcare investing.

Bain Capital’s O’Reilly says it’s a good time for healthcare IT and PIPEs; FTV’s Mason is excited about digital health

Bain Capital's O'Reilly discusses healthcare IT investing.

FTV's Alex Mason: 'We’re excited about all things digital health'

'As we think about the massive amount of paper still in healthcare, the inefficiency of payment transfers and payment modalities, that’s another huge avenue for us,' said FTV’s Mason.

Blackstone and Apollo take different tacks on entertainment; auto services attract PE firms

Blackstone and Apollo adopt opposite strategies when it comes to investing in the entertainment space.

Thoma Bravo invests in mental health company Alma; PE-backed TAG expands to vets

Thoma Bravo announced a $130 million minority growth investment in Alma.

Avista picks up OTC drug developer Wellspring from Audax

‘The diversified and highly established nature of WellSpring’s product portfolio, coupled with a strong innovation pipeline and exciting growth opportunities in e-commerce, was very compelling,’ said Avista’s Yu.

Multiples remain stable in healthcare, says WCAS’s Regan; mid-market deal flow still good, says Firmament’s Boyd

WCAS GP Regan discusses healthcare investing.

Firmament's Parris Boyd sees good deal flow in lower-mid-market healthcare deals

“Our debt-to-equity ratio really hasn't changed that much, despite the rise in interest rates, because we're not aggressive on leverage,” he said.

FTV’s Alex Mason parses Amazon-One Medical deal; BC Partners bullish on 2023

PE Hub talks to WCAS' head of healthcare group Regan.

Healthcare M&A should be ‘robust’; Vistria’s Kip Kirkpatrick goes off-duty

PE Hub Europe discusses trends of PE firms investing in soccer clubs.